Sign Up to like & get
recommendations!
1
Published in 2020 at "Leukemia"
DOI: 10.1038/s41375-020-0836-7
Abstract: Infection with SARS-CoV-2, the cause of coronavirus infectious disease–19 (COVID-19), has caused a pandemic with >850,000 cases worldwide and increasing. Several studies report outcomes of COVID-19 in predominately well persons. There are also some data…
read more here.
Keywords:
health care;
care providers;
haematological cancers;
persons haematological ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2020 at "Leukemia"
DOI: 10.1038/s41375-020-0914-x
Abstract: We read with interest the article titled “COVID-19 in persons with haematological cancers” by Wenjuan He et al. published recently [1]. The authors conducted a retrospective cohort study of 13 hospitalized patients with hematological malignancies…
read more here.
Keywords:
haematological cancers;
persons haematological;
covid persons;
covid ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2017 at "British Journal of Haematology"
DOI: 10.1111/bjh.14617
Abstract: Cancer is increasingly important in low and middle‐income settings where infectious diseases are declining. Childhood cancers treated in well‐resourced centres have excellent outcomes with more than 80% survival. This success is not reflected in low‐income…
read more here.
Keywords:
progress challenges;
haematological cancers;
children progress;
cancers african ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2022 at "BMJ Open"
DOI: 10.1136/bmjopen-2021-050816
Abstract: Objectives Haematological malignancies are the fifth most common cancer in the UK, with chronic subtypes comprising around a third of all new diagnoses. These complex diseases have some similarities with other cancers, but often require…
read more here.
Keywords:
patients chronic;
treatment decision;
decision making;
chronic haematological ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2021 at "AntiCancer Research"
DOI: 10.21873/anticanres.14871
Abstract: Haematology has been at the forefront of cancer immunotherapy advancements. Allogeneic haematopoietic stem cell transplant (allo-HSCT) is one of the earliest forms of cancer immunotherapy and continues to cure thousands of patients. Donor lymphocyte infusion…
read more here.
Keywords:
haematological cancers;
adoptive cell;
cell based;
based immunotherapies ... See more keywords